704 related articles for article (PubMed ID: 19342865)
1. Vasculitic IgA nephropathy: prognosis and outcome.
Pankhurst T; Lepenies J; Nightingale P; Howie AJ; Adu D; Harper L
Nephron Clin Pract; 2009; 112(1):c16-24. PubMed ID: 19342865
[TBL] [Abstract][Full Text] [Related]
2. Treatment of vasculitic IgA nephropathy.
Harper L; Ferreira MA; Howie AJ; Savage CO; Richards NT; Michael J; Adu D
J Nephrol; 2000; 13(5):360-6. PubMed ID: 11063140
[TBL] [Abstract][Full Text] [Related]
3. Factors predicting progression of IgA nephropathies.
Coppo R; D'Amico G
J Nephrol; 2005; 18(5):503-12. PubMed ID: 16299675
[TBL] [Abstract][Full Text] [Related]
4. The impact of sex in primary glomerulonephritis.
Cattran DC; Reich HN; Beanlands HJ; Miller JA; Scholey JW; Troyanov S;
Nephrol Dial Transplant; 2008 Jul; 23(7):2247-53. PubMed ID: 18182409
[TBL] [Abstract][Full Text] [Related]
5. Can immunosuppressive drugs slow the progression of IgA nephropathy?
Goumenos D; Ahuja M; Shortland JR; Brown CB
Nephrol Dial Transplant; 1995; 10(7):1173-81. PubMed ID: 7478120
[TBL] [Abstract][Full Text] [Related]
6. Steroid and cyclophosphamide therapy for IgA nephropathy associated with crescenteric change: an effective treatment.
McIntyre CW; Fluck RJ; Lambie SH
Clin Nephrol; 2001 Sep; 56(3):193-8. PubMed ID: 11597033
[TBL] [Abstract][Full Text] [Related]
7. [Henoch-Schönlein purpura].
Pillebout E; Niaudet P
Rev Prat; 2008 Mar; 58(5):507-11. PubMed ID: 18524107
[TBL] [Abstract][Full Text] [Related]
8. Recurrence of IgA nephropathy and Henoch-Schönlein purpura after kidney transplantation: risk factors and graft survival.
Soler MJ; Mir M; Rodriguez E; Orfila A; Munne A; Vázquez S; Lloveras J; Puig JM
Transplant Proc; 2005 Nov; 37(9):3705-9. PubMed ID: 16386512
[TBL] [Abstract][Full Text] [Related]
9. Treatment of severe Henoch-Schönlein nephritis: justifying more immunosuppression.
Altugan FS; Ozen S; Aktay-Ayaz N; Güçer S; Topaloğlu R; Düzova A; Ozaltin F; Beşbaş N
Turk J Pediatr; 2009; 51(6):551-5. PubMed ID: 20196388
[TBL] [Abstract][Full Text] [Related]
10. Presentation, prognosis and outcome of IgA nephropathy in Indian adults.
Chacko B; John GT; Neelakantan N; Korula A; Balakrishnan N; Kirubakaran MG; Jacob CK
Nephrology (Carlton); 2005 Oct; 10(5):496-503. PubMed ID: 16221102
[TBL] [Abstract][Full Text] [Related]
11. Prognostic factors and therapy assessment of IgA nephropathy: report from a single unit in iran.
Soleymanian T; Najafi I; Salimi BH; Broomand B
Ren Fail; 2011; 33(6):572-7. PubMed ID: 21663387
[TBL] [Abstract][Full Text] [Related]
12. Multivariate analysis of prognostic factors and effect of treatment in patients with IgA nephropathy.
Komatsu H; Fujimoto S; Hara S; Sato Y; Yamada K; Eto T; Nakao H
Ren Fail; 2005; 27(1):45-52. PubMed ID: 15717634
[TBL] [Abstract][Full Text] [Related]
13. The spectrum of acute renal failure in IgA nephropathy.
Wen YK; Chen ML
Ren Fail; 2010 May; 32(4):428-33. PubMed ID: 20446779
[TBL] [Abstract][Full Text] [Related]
14. IgA nephropathy and Henoch-Schönlein purpura nephritis.
Sanders JT; Wyatt RJ
Curr Opin Pediatr; 2008 Apr; 20(2):163-70. PubMed ID: 18332712
[TBL] [Abstract][Full Text] [Related]
15. Henoch-Schoenlein nephritis and IgA nephropathy in children: a comparison of clinical course.
Yoshikawa N; Ito H; Yoshiya K; Nakahara C; Yoshiara S; Hasegawa O; Matsuyama S; Matsuo T
Clin Nephrol; 1987 May; 27(5):233-7. PubMed ID: 3594938
[TBL] [Abstract][Full Text] [Related]
16. Henoch-Schönlein purpura-like presentation in IgA-dominant Staphylococcus infection - associated glomerulonephritis - a diagnostic pitfall.
Satoskar AA; Molenda M; Scipio P; Shim R; Zirwas M; Variath RS; Brodsky SV; Nadasdy GM; Hebert L; Rovin B; Nadasdy T
Clin Nephrol; 2013 Apr; 79(4):302-12. PubMed ID: 23320971
[TBL] [Abstract][Full Text] [Related]
17. [Clinical aspects of the nephropathy in Schoenlein-Henoch syndrome].
Verrina E; Perfumo F; Canepa A; Ginevri F; Gusmano R
Pediatr Med Chir; 1986; 8(3):317-20. PubMed ID: 3786192
[TBL] [Abstract][Full Text] [Related]
18. Long-term outcome of Schönlein-Henoch nephritis in the adult.
Fogazzi GB; Pasquali S; Moriggi M; Casanova S; Damilano I; Mihatsch MJ; Zucchelli P; Ponticelli C
Clin Nephrol; 1989 Feb; 31(2):60-6. PubMed ID: 2646052
[TBL] [Abstract][Full Text] [Related]
19. [The course and prognosis of mesangioproliferative glomerulonephritis].
Shilov EM; Tareeva IE; Ivanov AA; Troepol'skaia OV; Krasnova TN; Varshavskiĭ VA; Proskurneva EP; Ivanova LV; Khudova IIu; Miroshnichenko NG
Ter Arkh; 2002; 74(6):11-8. PubMed ID: 12136475
[TBL] [Abstract][Full Text] [Related]
20. [The incidence of renal diseases as diagnosed by biopsy in Hungary].
Sipiczki T; Ondrik Z; Abrahám G; Pokorny G; Túri S; Sonkodi S; Kemény E; Iványi B
Orv Hetil; 2004 Jun; 145(26):1373-9. PubMed ID: 15384747
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
